Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiki Chang

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Child and Adolescent Psychopharmacology|May 31, 2018
Neurofunctional Correlates of Response to Quetiapine in Adolescents with Bipolar DepressionKiki Chang, Melissa DelBello, Amy Garrett, et al.
Journal of Child and Adolescent Psychopharmacology|October 12, 2013
Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophreniaDavid E Kemp, Christoph U Correll, Mauricio Tohen, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 25, 2015
Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I DisorderRobert L Findling, Ronald L Landbloom, Armin Szegedi, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 25, 2015
Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal StudyRobert L Findling, Kiki Chang, Adelaide Robb, et al.
Developmental Neuroscience|April 6, 2025
Defining Clinical Course of Patients Evaluated for Pediatric Acute-Onset Neuropsychiatric Syndrome: Phenotypic Classification Based on 10 Years of Clinical DataErin E Masterson, Kate Miles, Noelle Schlenk, et al.
Comprehensive Psychiatry|April 24, 2012
Health-related quality of life as measured by the child health questionnaire in adolescents with bipolar disorder treated with olanzapineBrian T Olsen, Stephen J Ganocy, Samantha M Bitter, et al.
Journal of Child and Adolescent Psychopharmacology|February 7, 2015
Antineuronal antibodies in a heterogeneous group of youth and young adults with tics and obsessive-compulsive disorderCarol J Cox, Amir J Zuccolo, Erica V Edwards, et al.
Journal of Affective Disorders|November 6, 2012
Socio-emotional processing and functioning of youth at high risk for bipolar disorderJane Whitney, Meghan Howe, Virginia Shoemaker, et al.
The Journal of Clinical Psychiatry|November 13, 2009
Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled studyRobert L Findling, Margaretta Nyilas, Robert A Forbes, et al.
The Journal of Clinical Psychiatry|September 19, 2017
Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled TrialLe Xiao, Stephen J Ganocy, Robert L Findling, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Child and Adolescent Psychopharmacology|May 31, 2018
Neurofunctional Correlates of Response to Quetiapine in Adolescents with Bipolar DepressionKiki Chang, Melissa DelBello, Amy Garrett, et al.
Journal of Child and Adolescent Psychopharmacology|October 12, 2013
Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophreniaDavid E Kemp, Christoph U Correll, Mauricio Tohen, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 25, 2015
Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I DisorderRobert L Findling, Ronald L Landbloom, Armin Szegedi, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 25, 2015
Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal StudyRobert L Findling, Kiki Chang, Adelaide Robb, et al.
Developmental Neuroscience|April 6, 2025
Defining Clinical Course of Patients Evaluated for Pediatric Acute-Onset Neuropsychiatric Syndrome: Phenotypic Classification Based on 10 Years of Clinical DataErin E Masterson, Kate Miles, Noelle Schlenk, et al.
Comprehensive Psychiatry|April 24, 2012
Health-related quality of life as measured by the child health questionnaire in adolescents with bipolar disorder treated with olanzapineBrian T Olsen, Stephen J Ganocy, Samantha M Bitter, et al.
Journal of Child and Adolescent Psychopharmacology|February 7, 2015
Antineuronal antibodies in a heterogeneous group of youth and young adults with tics and obsessive-compulsive disorderCarol J Cox, Amir J Zuccolo, Erica V Edwards, et al.
Journal of Affective Disorders|November 6, 2012
Socio-emotional processing and functioning of youth at high risk for bipolar disorderJane Whitney, Meghan Howe, Virginia Shoemaker, et al.
The Journal of Clinical Psychiatry|November 13, 2009
Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled studyRobert L Findling, Margaretta Nyilas, Robert A Forbes, et al.
The Journal of Clinical Psychiatry|September 19, 2017
Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled TrialLe Xiao, Stephen J Ganocy, Robert L Findling, et al.
Pageof 6